Welcome to LookChem.com Sign In|Join Free
  • or
α-Methyl-DL-tyrosine is a synthetic amino acid derivative, characterized by the presence of a methyl group attached to the α-carbon of the tyrosine molecule. It is a racemic mixture, meaning it contains equal parts of both the D and L isomers. α-Methyl-DL-tyrosine is structurally similar to the naturally occurring amino acid tyrosine, which is a precursor in the biosynthesis of neurotransmitters such as dopamine, norepinephrine, and epinephrine. Due to its structural similarity, α-Methyl-DL-tyrosine can act as a competitive inhibitor of the enzyme tyrosine hydroxylase, which is crucial for the production of these neurotransmitters. This inhibition can lead to a decrease in the levels of catecholamines in the body, which has therapeutic applications in conditions such as hypertension and pheochromocytoma. The compound is also used in scientific research to study the effects of tyrosine on various physiological processes.

2370-56-1

Post Buying Request

2370-56-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2370-56-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2370-56-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,7 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2370-56:
(6*2)+(5*3)+(4*7)+(3*0)+(2*5)+(1*6)=71
71 % 10 = 1
So 2370-56-1 is a valid CAS Registry Number.

2370-56-1Relevant academic research and scientific papers

Synthesis and in vitro opioid activity profiles of DALDA analogues

Schiller, Peter W.,Nguyen, Thi M.-D.,Berezowska, Irena,Dupuis, Sebastien,Weltrowska, Grazyna,Chung, Nga N.,Lemieux, Carole

, p. 895 - 901 (2007/10/03)

The tetrapeptide DALDA (H-Tyr-D-Arg-Phe-Lys-NH2) is a polar and selective μ agonist showing poor penetration of the placental and blood-brain barriers. In an effort to enhance the potency of DALDA, analogues containing 2',6'-dimethyltyrosine (Dmt), N,2',6'-trimethyltyrosine (Tmt), 2'-methyltyrosine (Mmt) or 2'-hydroxy,6'-methyltyrosine (Hmt) in place of Tyr1, or Orn or α,γ-diaminobutyric acid (A2bu) in place of Lys4, were synthesized. All compounds displayed high it receptor selectivity in the rat and guinea pig brain membrane binding assays and most of them were more potent μ agonists than DALDA in the μ receptor-representative guinea pig ileum assay, with [Dmt1]DALDA showing the highest potency. Because of its extraordinary μ agonist potency, high μ selectivity, polar character (charge of 3 +) and metabolic stability, [Dmt1]DALDA has potential for use in obstetrical or peripheral analgesia. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Tyrosine analogues as alternative substrates for protein tyrosine kinase Csk: Insights into substrate selectivity and catalytic mechanism

Kim, Kyonghee,Parang, Keykavous,Lau, Ontario D.,Cole, Philip A.

, p. 1263 - 1268 (2007/10/03)

Protein tyrosine kinases are critical enzymes in cell signal transduction but relatively little is known about the molecular recognition of the tyrosine substrate by these enzymes. Details of tyrosine substrate specificity within the context of a short peptide were investigated for protein tyrosine kinase Csk. It was found that aryl ring functional group substitutions the size of methyl group or smaller were generally well tolerated by the protein tyrosine kinase Csk whereas larger groups caused a decline in substrate efficiency. Extension of the phenol from the peptide backbone by a single methylene was acceptable for phosphorylation whereas removal of a methylene nearly abolished reactivity. Only the L-tyrosine derivative was processed. A negative charge ortho to the phenol hydroxyl was incompatible with substrate reactivity, consistent with previous pH rate profiles which indicated the importance of the neutral phenol. Overall, these studies confirmed the interpretation of a previous linear free energy relationship analysis which suggested that the enzyme followed a dissociative transition state mechanism. Copyright (C) 2000 Elsevier Science Ltd.

Pharmaceutically active fluoromethyltyrosine compounds

-

, (2008/06/13)

This invention relates to novel monofluoromethyl- and difluoromethyltyrosine compounds which are active as tyrosine hydroxylase inhibitors and are therefore useful in the treatment of conditions caused by high levels of catecholamines such as hypertension

Syntheses ofDL-2-fluoromethy-P-tyrosine andDL-2-difluoromethyl-P-tyrosine as potential inhibitors of tyrosine hydroxylase

McDonald, Ian A.,Nyce, Philip L.,Jung, Michel J.,Sabol, Jeffrey S.

, p. 887 - 890 (2007/10/02)

The syntheses of the title compounds from 3,4-dimethylanisole and ethyl 5-hydroxy-2-methylbenzoate, respectively, are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2370-56-1